Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency

S. K. Austin, C. Brindley, K. Kavakli, M. Norton, A. Shapiro
  • Haemophilia, February 2016, Wiley
  • DOI: 10.1111/hae.12894

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/hae.12894

The following have contributed to this page: Dr Nuria Bermejo and Miranda Norton